Molecule
Atosiban
- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Atosiban is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- G02CX01 Atosiban · Other gynaecological medicines, subgroup G02C, subgroup G02CX
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Identifiers
- UNII 081D12SI0ZRxCUI 59639CAS 90779-69-4DrugBank DB09059Q421322
All presentations
No presentations of Atosiban are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Atosiban available for export from India?
No presentation of Atosiban is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Atosiban authorised in the European Union?
Yes. Atosiban has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Atosiban need cold chain shipping?
No listed presentation of Atosiban is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Atosiban in?
Atosiban is classified under ATC code G02CX01 (Atosiban).
References
- Tractocile: European public assessment report (EPAR). European Medicines Agency. Retrieved 30 March 2022
- Atosiban SUN: European public assessment report (EPAR). European Medicines Agency. Retrieved 20 June 2024
Request Atosiban for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.